The Macrophage-directed Therapies Summit is the only industry focused forum dedicated to all macrophage-based approaches, including gene engineered cell therapy, CD47 targeting and reprogramming technologies.
Download the brochure to see why this event is unmissable for 2022, to enable you to achieve safe, efficacious, and controllable macrophage-directed therapies.
Join us in Boston this October to:
- SECURE clinical validation through multiple clinical updates from a range of programs targeting CD47, utilizing CAR-Ms and small molecule repolarization
- EXPLORE how macrophages can be controlled using novel exosome and in vivo approaches and DISCOVER novel applications for macrophages outside oncology
- EVALUATE dosing strategies, DETERMINE optimal combinations and IMPROVE model translatability to enhance therapy safety and efficacy in the clinic